Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

NCT06533865 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

FHA (Functional Hypothalamic Amenorrhea)

Interventions

DRUG: Romosozumab
DRUG: Placebo
DRUG: Zoledronic acid

Sponsor

Massachusetts General Hospital